Related Experiment Video

Updated: Apr 15, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K

Laurus nobilis L. Seed Extract Reveals Collateral Sensitivity in Multidrug-Resistant P-Glycoprotein-Expressing Tumor

Antoine M Saab1, Alessandra Guerrini, Maen Zeino

  • 1a Faculty of Sciences II , Lebanese University , Chemistry Department , Beirut , Lebanon.

Nutrition and Cancer
|April 4, 2015
PubMed

Insights

Laurus nobilis seed extract shows promise in treating drug-resistant cancers. This natural compound effectively kills multidrug-resistant leukemia cells, offering a new avenue for chemotherapy development.

Area of Science:

  • Phytochemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Standard cancer chemotherapy frequently fails due to drug-resistant tumors.
  • Novel therapeutic strategies are needed to overcome multidrug resistance (MDR).
  • Laurelus nobilis (bay laurel) is a plant with potential medicinal properties.

Purpose of the Study:

  • To investigate the potential of Laurus nobilis seed extract as a novel anticancer agent.
  • To evaluate the efficacy of the extract against multidrug-resistant cancer cells.
  • To elucidate the mechanism of action against P-glycoprotein-expressing tumors.

Main Methods:

  • Chemical characterization of Laurus nobilis seed extract using GC/FID, GC/MS, and 1H NMR.
  • Assessment of cellular sensitivity using flow cytometry to measure apoptosis.
  • Analysis of gene expression profiles and P-glycoprotein substrate accumulation.

Main Results:

  • The Laurus nobilis seed extract demonstrated collateral sensitivity in multidrug-resistant P-glycoprotein-expressing leukemia cells.
  • The extract was effective against cells resistant to doxorubicin, a common chemotherapy drug.
  • Specific compounds within the extract did not correlate with P-glycoprotein expression or resistance markers.

Conclusions:

  • Laurus nobilis seed extract is effective in killing multidrug-resistant, P-glycoprotein-expressing tumor cells.
  • The extract represents a potential therapeutic candidate for overcoming chemotherapy resistance.
  • Further research into the specific active components and mechanisms is warranted.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.1K

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
158
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
71
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K